Current Oncology, Free Full-Text
Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we discuss the current standard-of-care treatment options for metastatic TNBC, including recent advances with the use of immunotherapy, PARP inhibitors and antibody-drug conjugates. This review also explores new agents and novel combinations arising in the field for the treatment of advanced TNBC.
Cancer Facts & Figures 2023
Current Oncology, Free Full-Text
Current Oncology, Free Full-Text
Molecular Oncology - Wiley Online Library
Current Oncology January 2023 - Browse Articles
Harrison's hematology and oncology : Free Download, Borrow, and
Current Oncology, Free Full-Text
Current Oncology, Free Full-Text
Current Oncology January 2024 - Browse Articles
Camp One Step provides free camp experience for kids with cancer